When Will Psilocybin Be Available in Oregon and What’s the Hold-Up?
The Oregon Health Authority has until December 31, 2022, to finalize the framework, paving the way for licensure in early 2023.
Entries by Carrie Dagenhard
How Psychedelic Treatment Through Canada’s SAP Works
Two psychedelic industry insiders reflect on the progress and flaws within Health Canada’s recent amendment to the Special Access Program.
Promising Psychedelic Therapy Legislation Set to Make Waves in 2022
California’s not alone. Florida, Michigan, New York, and more U.S. states may pass psychedelic therapy or decriminalization legislation in 2022, while Canada kicked off the year with more access.
Why Psychedelic Research May Bring the Next Big Breakthrough in Dementia Treatment
“Psychedelics are well-observed to basically rewire the brain,” says Return Health CEO Dr. James Kuo, who is currently working with DMT because it’s shown the most efficacy in neurogenesis.
Understanding HPPD to Prioritize Harm Reduction of a Very Real Psychedelic Risk
“HPPD is precisely the kind of risk that could fall through the cracks,” says journalist Ed Prideaux, who suffers from the condition and advocates for more research.
How Dr. Monnica Williams Created Canada’s First Psychedelic Master’s Degree Program: ‘Nobody Took Me Seriously’
After two long years of preparing documents and presenting to various committees, the program is in its final stages, and the University of Ottawa will soon begin accepting applications for the fall semester.
How Nutrition Can Improve the Psychedelic Experience
Focus on these five key nutrients to better support your body and increase the likelihood of enjoying your psychedelic experience.
Walled Garden: Fighting for Inclusivity and Accessibility in the Psychedelic Renaissance
As the new industry blooms, researchers and other professionals are fighting to break down barriers to participation, information, and psychedelics themselves.
